Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infectious diseases, announced today the FDA's clearance

Stocks To Watch: 6 Big Movers With Upside

12:00am, Tuesday, 02'nd Jun 2020
Stocks Analysis by Harry Boxer covering: Pan American Silver Corp, Ballard Power Systems Inc, Apache Corporation, Owens-Illinois Inc. Read Harry Boxer's latest article on Investing.com
The Parishad convener, Jatin Goswami, said in a statement in Gauhati that the so-called all party conference to evolve a consensus on the foreigners’ issue was attended only by left parties which ha
Investors need to pay close attention to Agenus (AGEN) stock based on the movements in the options market lately.

72 Biggest Movers From Friday

08:53am, Monday, 01'st Jun 2020
Instagram will test IGTV ads this year with individual creators and share 55% of ad revenue.
A case has been registered against opposition leader Ramesh Chennithala among 20 other Congress workers for violating social distancing norms and lockdown guidelines to participate in agitation in Tho
According to Kantar IMRB ICUBE report, we currently have over 574 million internet users, which is projected to reach 639 million by the end of December

Here's Why Agenus Rose as Much as 23.3% Today

05:28pm, Friday, 29'th May 2020
Shares of Agenus (NASDAQ: AGEN) jumped over 23% today after the company announced a presentation at the American Society of Clinical Oncology (ASCO) meeting discussing the progress of AGEN1181 in soli
Protalix (PLX) announces submission of regulatory application seeking approval for its lead pipeline candidate, pegunigalsidase alfa, for Fabry disease.
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers and infections, announced the American Society of Clinical O
May 28, 2020 (SmarTrend(R) News Watch via COMTEX) -- Agenus Inc (NASDAQ:AGEN) traded in a range yesterday that spanned from a low of $2.74 to a high of...
Mersana's (MRSN) antibody-drug conjugate candidate, XMT-1536, achieves encouraging response rate in interim analysis of a phase I study in ovarian cancer patients.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE